title: Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
authors.affiliation: Delhi Dermpath Laboratory, Delhi Dermatology Group, New Delhi, India.
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Batrani
authors.affiliation: Department of Pathology, Rao Tula Ram Hospital, New Delhi, India.
authors.forename: Manish
authors.initials: M
authors.lastname: Salhotra
authors.affiliation: Delhi Dermpath Laboratory, Delhi Dermatology Group, New Delhi, India.
authors.forename: Asha
authors.initials: A
authors.lastname: Kubba
authors.affiliation: Department of Dermatology, Fortis Hospital, New Delhi, India.
authors.forename: Manjul
authors.initials: M
authors.lastname: Agrawal
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy*; D011164:Porphyrias / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate